About Sophia Langlois
Sophia Langlois is a director at Keenova Therapeutics plc.
Form D filings name Sophia Langlois as a director at Endo.
Sophia Langlois reports to the SEC as a director of 1 public company.
Sophia Langlois first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Sophia Langlois in the role, so the role may have started earlier or lasted longer.
KP
Keenova Therapeutics plc
Director
2025 – 2026 · Public company
Key Colleagues at Startups
The people Sophia Langlois works with at each company, as listed on that company's latest Form D.
Endo, Inc. · Form D/A, May 6, 2024
SH
Scott Hirsch
Director
PE
Paul Efron
Director
PH
Paul Herendeen
Director
MY
Marc Yoskowitz
Director
PB
Patrick Barry
Executive Vice President; President, Global Commercial Operations
BC
Blaise Coleman
President; Chief Executive Officer and director
MM
Matthew Maletta
Executive Vice President; Chief Legal Officer; Secretary
FR
Frank Raciti
Vice President; Controller; Chief Accounting Officer
MB
Mark Bradley
Executive Vice President; Chief Financial Officer and director
AP
Andy Pasternak
Director